Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortChemotherapy that also treats severe autoimmune disease.Powerful red chemotherapy for breast cancer, lymphoma and sarcoma.
Body systemCancerCancer
Drug classAlkylating agentsAnthracyclines
SupplyPrescription onlyWHO essential medicinePrescription onlyWHO essential medicine
Main usesLymphoma, Breast cancer, Leukaemia, Severe lupus and vasculitis, Before stem cell transplantsBreast cancer, Lymphomas, Leukaemias, Sarcomas, Many childhood cancers
How it worksDamages DNA so dividing cells die.Damages cancer cell DNA so they can't divide.
Starts working——
Half-life——
Typical adult doseVaries widely by condition and regimen.Dose by body surface area per cycle; lifetime maximum around 450–550 mg/m².
FormsIV infusion, TabletIV infusion, Liposomal infusion
Common side effectsNausea, Hair loss, Low blood countsHair loss, Nausea, Mouth sores, Red urine (1–2 days), Low blood counts
Serious side effectsBleeding from the bladder, Infertility, Secondary cancers, InfectionsHeart damage (dose-related, can appear years later), Severe tissue damage if it leaks from the vein, Secondary leukaemia (rare)
Don't take if——
Alcohol——
PregnancyUsually avoidedCauses birth defects.Usually avoidedAvoided in the first trimester; sometimes given later under specialists.
Breastfeeding——
In use since19591974
Brand namesUnited States: Cytoxan (historic)United Kingdom: CyclophosphamideIndia: Endoxan, CyclomideUnited States: Adriamycin, DoxilUnited Kingdom: CaelyxIndia: Adriamycin, Lipodox
Legal status——
ATC codeL01AA01L01DB01

Taken together

  • ModerateCyclophosphamide + Doxorubicin: Added bone marrow suppression

    Both can lower white cells, red cells or platelets; together the risk of infection and bleeding rises.

Open in the interaction checker